Yhtiökokouskutsu
February 28, 2006 02:05 ET
|
Kesko Oyj
Kokouksessa käsitellään seuraavat yhtiöjärjestyksen 12 §:n mukaan varsinaiselle yhtiökokoukselle kuuluvat asiat
1. Tilinpäätöksen ja tilintarkastuskertomuksen esittäminen sekä tilinpäätöksen...
TGS Announces Major New GOM Deepwater 3D Survey
February 28, 2006 02:02 ET
|
TGS ASA
TGS Announces Major New Gulf of Mexico Deepwater 3D Survey
Houston, Texas and Naersnes, Norway (28 February 2006) - TGS-NOPEC Geophysical Company (TGS) announced today that it will acquire a new...
TGS Announces Major New GOM Deepwater 3D Survey
February 28, 2006 02:02 ET
|
TGS ASA
TGS Announces Major New Gulf of Mexico Deepwater 3D Survey
Houston, Texas and Naersnes, Norway (28 February 2006) - TGS-NOPEC Geophysical Company (TGS) announced today that it will acquire a new...
Notice of Annual General Meeting
February 28, 2006 02:01 ET
|
Kesko Oyj
The following matters, in accordance with Article 12 of the Articles of Association, will be on the agenda of the Meeting
1. Presentation of the financial statements and the audit report,...
MorphoSys Achieves Fourth Therapeutic Milestone in Centocor Collaboration
February 28, 2006 01:56 ET
|
MorphoSys AG
MARTINSRIED, Germany, Feb. 28, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard:MOR) today announced the achievement of a fourth therapeutic milestone within the scope of its...
PhotoCure ASA - Results 2005
February 28, 2006 01:46 ET
|
Photocure ASA
Oslo, Norway, 28 February 2006
PhotoCure ASA (Oslo Stock Exchange: PHO) presents today its results for 2005. The main items in the report are:
Hexvix approved in Europe and...
PhotoCure ASA - Årsresultater 2005
February 28, 2006 01:46 ET
|
Photocure ASA
Oslo, 28. februar 2006
PhotoCure ASA (Oslo Børs: PHO) legger i dag frem resultatene for 2005. Hovedpunkter fra rapporten er:
Hexvix godkjent i Europa og søkand sendt i USA Hexvix...
Basilea Pharmaceutica Ltd. Reports 2005 Financial Results
February 28, 2006 01:38 ET
|
Basilea Pharmaceutica Ltd
BASEL, Switzerland, Feb. 28, 2006 (PRIMEZONE) -- Basilea (SWX:BSLN) announced 2005 financial results reflecting positive operating cash flow. Payments from Basilea's license partner, Johnson &...
Basilea Pharmaceutica AG (SWX:BSLN) präsentiert den Geschäftsbericht 2005
February 28, 2006 01:15 ET
|
Basilea Pharmaceutica AG
Basel, 28. Februar 2006
Basilea präsentiert die Jahreszahlen 2005, die einen positiven Kapitalfluss aus operativer Tätigkeit widerspiegeln. Die Zahlungen vom Lizenzpartner Johnson &...
Basilea Pharmaceutica Ltd. (SWX:BSLN) Reports 2005 Financial Results
February 28, 2006 01:15 ET
|
Basilea Pharmaceutica AG
Basel, Switzerland, 28th February 2006
Basilea announced 2005 financial results reflecting positive operating cash flow. Payments from Basilea's license partner, Johnson & Johnson exceed...
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California